Morphine should be used with caution at the end of life in covid patients – Vetenskapsradion Nyheter



[ad_1]

Maryland. Shahidul Islam is a molecular physician at the Karolinska Institutet and a critic with parts of the council of the National Board of Health and Welfare.

– Its a big problem. It’s almost outrageous. The basic principle of palliative care is that palliative care should not transfer from cancer to other diseases. It must adapt, says molecular physician Md Sahidul Islam. He sees the risk that morphine will further impair breathing in patients with covidity in the final stages of life. Also, ask for caution when administering morphine.

The state of research for care at the end of life it is weak. The Science Radio review shows that only one clinical study is being conducted, in Lyon, France, to investigate the effect of morphine in patients with covidity nearing the end of life.

Pulmonary physician Magnus Ekström at Blekinge Hospital, who investigates shortness of breath and morphine before death occurs, believes that the only way to handle the situation now is to use experience from other illnesses.

– What should we do? Shouldn’t we give any treatment? Or should we think the best we can and try to use what we know? Magnus Ekström asks.

In the National Board of Health and Welfare it means Thomas Linden, chief physician, said it is important to be careful when using morphine in covid patients.

– I agree with Shahidul that the question of dosage is very important. Because the goal of treatment in the final stages of life is to have a patient awake, lucid and without pain or anxiety. So you can’t give too much morphine and midazolam, because it lowers the patient’s consciousness and takes away that quality dimension, says chief physician Tomas Lindén of the National Board of Health and Well-being.

Vetenskapsradion Hälsa is now available on SR Play and there you can hear more about morphine and covid-19.

[ad_2]